Sagimet Biosciences To Host Virtual Investor And Analyst Day On Inhibiting Fatty Acid Synthase (FASN) To Reduce Liver Fat, Inflammation And Fibrosis In MASH On May 23, 2024

Press/Media

Period16 May 2024

Media coverage

1

Media coverage

  • TitleSagimet Biosciences To Host Virtual Investor And Analyst Day On Inhibiting Fatty Acid Synthase (FASN) To Reduce Liver Fat, Inflammation And Fibrosis In MASH On May 23, 2024
    Media name/outletMENAFN -Press Releases (English)
    Country/TerritoryJordan
    Date16/05/24
    PersonsScott Friedman